Cytomedix Inc (NUOTQ) SEC Filing 10-K Annual report for the fiscal year ending Friday, December 31, 2010

Nuo Therapeutics, Inc.

CIK: 1091596 Ticker: NUOTQ

View differences made from one year to another to evaluate Nuo Therapeutics, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Nuo Therapeutics, Inc..


Assess how Nuo Therapeutics, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Nuo Therapeutics, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2011 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


Ticker: NUOTQ
CIK: 1091596
Form Type: 10-K Annual Report
Accession Number: 0001144204-11-018428
Submitted to the SEC: Wed Mar 30 2011 5:25:55 PM EST
Accepted by the SEC: Wed Mar 30 2011
Period: Friday, December 31, 2010
Industry: Surgical And Medical Instruments And Apparatus

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: